The French In Vitro Diagnostics (IVD) market is booming, projected to reach €4.46 billion by 2033 with a 7.5% CAGR. Driven by chronic disease prevalence, technological advancements, and government initiatives, this report analyzes market segments, key players (Danaher, Becton Dickinson, Roche, etc.), and future growth prospects in France's thriving healthcare sector.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.